BioSpace News Archive

Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks.

Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program.

Masimo Corporation (Nasdaq: MASI) (“Masimo” or the “Company”) will host its Investor Day today.

Takeda (TSE:4502/NYSE:TAK) today announced that it will acquire NDI-034858 from Nimbus Therapeutics. NDI-034858 is an oral, selective allosteric tyrosine kinase 2 (TYK2) inhibitor being evaluated for the treatment of multiple autoimmune diseases following successful recent Phase 2b results in psoriasis.

Emergent Health Corp. (OTC PINK:EMGE) announces it has executed a letter of intent to Partner with Clicktivated Video, Inc. the first and only Fully Clickable Livestream Video to create Shoppable Content for its regenerative health and wellness products giving Emergent a Competitive Advantage to significantly increase Revenues.

Syneos Health®, the only fully integrated biopharmaceutical solutions organization, announced it has extended its strategic partnership with Medable, the industry-leading technology platform for patient-centered clinical trials, as part of the Company’s commitment to bring clinical trials closer to the patient.

Indaptus Therapeutics, Inc. today announces the initiation of INDP-D101, its first-in-human, open label, dose escalation and expansion, multicenter Phase 1 clinical trial of its lead compound Decoy20 in patients with advanced/metastatic solid tumors.

OpGen, Inc. today announced top line data from its successfully completed Unyvero UTI clinical trial. OpGen’s Unyvero UTI Panel tests for a broad range of bacterial and fungal pathogens as well as antimicrobial resistance markers directly from urine specimens.

Arbutus Biopharma Corporation today announced preliminary data from the AB-729 lead-in portion of its Phase 2a clinical trial combining AB-729 with nucleos(t)ide analogue (NA) therapy and Peginterferon alfa-2a (IFN).

Amedisys, Inc. has closed on its joint venture with the University of Arkansas for Medical Sciences (UAMS) to provide home health services in Searcy and Little Rock.